Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer

Gastric cancer is still the leading cause of cancer deaths, especially in Asian countries. Recently, many studies have analyzed cell-free nucleic acids (cfNAs) circulating in the blood, for the early diagnosis of cancer and monitoring its progression. Circulating tumor nucleic acids (ctNAs) originat...

Full description

Bibliographic Details
Main Authors: Hyun-Ji Lee, Sun Min Lee
Format: Article
Language:English
Published: Yong Chan Lee 2018-09-01
Series:The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Subjects:
Online Access:http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2018.18.3.168
id doaj-59f35cc5d129442c8d4cd8f4d1d1104a
record_format Article
spelling doaj-59f35cc5d129442c8d4cd8f4d1d1104a2020-11-24T22:47:59ZengYong Chan LeeThe Korean Journal of Helicobacter and Upper Gastrointestinal Research1738-33312018-09-0118316817310.7704/kjhugr.2018.18.3.168kjhugr.2018.18.3.168Circulating Cell-free Tumor Nucleic Acids in Gastric CancerHyun-Ji Lee0Sun Min Lee1Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Yangsan, KoreaDepartment of Laboratory Medicine, Pusan National University Yangsan Hospital, Yangsan, KoreaGastric cancer is still the leading cause of cancer deaths, especially in Asian countries. Recently, many studies have analyzed cell-free nucleic acids (cfNAs) circulating in the blood, for the early diagnosis of cancer and monitoring its progression. Circulating tumor nucleic acids (ctNAs) originate in a tumor and contain tumor-related genetic or epigenetic alterations. This review defines the nomenclatures of each form of cfNAs and describes the characteristics of circulating tumor DNA (ctDNA) and microRNA (miRNA), two major forms of ctNAs studied in gastric cancer research to date. We compare available studies on ctDNA, and explain trends observed in studies of miRNAs in gastric cancers. As these new blood-based biomarkers have attracted increasing attention, we have discussed several important points to be considered before the clinical translation of ctNA detection. We have also discussed the current status of research in this field, and clinical applications of specific ctNAs as tumor markers for gastric cancer diagnosis.http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2018.18.3.168Cell-free nucleic acidsCirculating microRNACirculating tumor DNALiquid biopsyStomach neoplasms
collection DOAJ
language English
format Article
sources DOAJ
author Hyun-Ji Lee
Sun Min Lee
spellingShingle Hyun-Ji Lee
Sun Min Lee
Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Cell-free nucleic acids
Circulating microRNA
Circulating tumor DNA
Liquid biopsy
Stomach neoplasms
author_facet Hyun-Ji Lee
Sun Min Lee
author_sort Hyun-Ji Lee
title Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
title_short Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
title_full Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
title_fullStr Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
title_full_unstemmed Circulating Cell-free Tumor Nucleic Acids in Gastric Cancer
title_sort circulating cell-free tumor nucleic acids in gastric cancer
publisher Yong Chan Lee
series The Korean Journal of Helicobacter and Upper Gastrointestinal Research
issn 1738-3331
publishDate 2018-09-01
description Gastric cancer is still the leading cause of cancer deaths, especially in Asian countries. Recently, many studies have analyzed cell-free nucleic acids (cfNAs) circulating in the blood, for the early diagnosis of cancer and monitoring its progression. Circulating tumor nucleic acids (ctNAs) originate in a tumor and contain tumor-related genetic or epigenetic alterations. This review defines the nomenclatures of each form of cfNAs and describes the characteristics of circulating tumor DNA (ctDNA) and microRNA (miRNA), two major forms of ctNAs studied in gastric cancer research to date. We compare available studies on ctDNA, and explain trends observed in studies of miRNAs in gastric cancers. As these new blood-based biomarkers have attracted increasing attention, we have discussed several important points to be considered before the clinical translation of ctNA detection. We have also discussed the current status of research in this field, and clinical applications of specific ctNAs as tumor markers for gastric cancer diagnosis.
topic Cell-free nucleic acids
Circulating microRNA
Circulating tumor DNA
Liquid biopsy
Stomach neoplasms
url http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2018.18.3.168
work_keys_str_mv AT hyunjilee circulatingcellfreetumornucleicacidsingastriccancer
AT sunminlee circulatingcellfreetumornucleicacidsingastriccancer
_version_ 1725680223790301184